| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cancer Research and Treatment Center [J. M. Y., A. P. L., and A. O. M.] and Departments of Radiology [J. M. Y., A. P. L.], and Anatomy [A. J. L.], University of New Mexico, Albuquerque, New Mexico 87131
A new technique, based on the growth of tumor cells in liquid media over an agar base, has been developed for the formation and growth of multicellular tumor spheroids. All of the 11 transformed cell lines tested formed multicellular tumor spheroids, while none of the 8 normal cell types tested did so. The advantages of the present technique over older methods include its simplicity, generality, and experimental flexibility.
1 Supported by the Division of Cancer Centers and Resources, National Cancer Institute, through Grant 1-P30-C-21074-01.
Received 4/11/77. Accepted 6/30/77.
This article has been cited by other articles:
![]() |
F. Hirschhaeuser, T. Leidig, B. Rodday, C. Lindemann, and W. Mueller-Klieser Test System for Trifunctional Antibodies in 3D MCTS Culture J Biomol Screen, September 1, 2009; 14(8): 980 - 990. [Abstract] [PDF] |
||||
![]() |
R. D. Braun and K. S. Vistisen Measurement of Human Choroidal Melanoma Xenograft Volume in Rats Using High-Frequency Ultrasound Invest. Ophthalmol. Vis. Sci., January 1, 2008; 49(1): 16 - 22. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Braun, M. Gradianu, K. S. Vistisen, R. L. Roberts, and B. A. Berkowitz Manganese-Enhanced MRI of Human Choroidal Melanoma Xenografts Invest. Ophthalmol. Vis. Sci., March 1, 2007; 48(3): 963 - 967. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Braun and A. Abbas Orthotopic Human Choroidal Melanoma Xenografts in Nude Rats with Aggressive and Nonaggressive PAS Staining Patterns Invest. Ophthalmol. Vis. Sci., January 1, 2006; 47(1): 7 - 16. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Heese, A. Disko, D. Zirkel, M. Westphal, and K. Lamszus Neural stem cell migration toward gliomas in vitro Neuro-oncol, October 1, 2005; 7(4): 476 - 484. [Abstract] [PDF] |
||||
![]() |
A. Soubry, J. van Hengel, E. Parthoens, C. Colpaert, E. Van Marck, D. Waltregny, A. B. Reynolds, and F. van Roy Expression and Nuclear Location of the Transcriptional Repressor Kaiso Is Regulated by the Tumor Microenvironment Cancer Res., March 15, 2005; 65(6): 2224 - 2233. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Emfietzoglou, K. Kostarelos, A. Papakostas, W.-H. Yang, A. Ballangrud, H. Song, and G. Sgouros Liposome-Mediated Radiotherapeutics Within Avascular Tumor Spheroids: Comparative Dosimetry Study for Various Radionuclides, Liposome Systems, and a Targeting Antibody J. Nucl. Med., January 1, 2005; 46(1): 89 - 97. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Ballangrud, W.-H. Yang, S. Palm, R. Enmon, P. E. Borchardt, V. A. Pellegrini, M. R. McDevitt, D. A. Scheinberg, and G. Sgouros Alpha-Particle Emitting Atomic Generator (Actinium-225)-Labeled Trastuzumab (Herceptin) Targeting of Breast Cancer Spheroids: Efficacy versus HER2/neu Expression Clin. Cancer Res., July 1, 2004; 10(13): 4489 - 4497. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Enmon, W.-H. Yang, A. M. Ballangrud, D. B. Solit, G. Heller, N. Rosen, H. I. Scher, and G. Sgouros Combination Treatment with 17-N-Allylamino-17-Demethoxy Geldanamycin and Acute Irradiation Produces Supra-Additive Growth Suppression in Human Prostate Carcinoma Spheroids Cancer Res., December 1, 2003; 63(23): 8393 - 8399. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. E. B. Stuhr, A. Reith, S. Lepsoe, R. Myklebust, H. Wiig, and R. K. Reed Fluid pressure in human dermal fibroblast aggregates measured with micropipettes Am J Physiol Cell Physiol, November 1, 2003; 285(5): C1101 - C1108. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Casey, K. M. Burleson, K. M. Skubitz, S. E. Pambuccian, T. R. Oegema Jr., L. E. Ruff, and A. P. N. Skubitz {beta}1-Integrins Regulate the Formation and Adhesion of Ovarian Carcinoma Multicellular Spheroids Am. J. Pathol., December 1, 2001; 159(6): 2071 - 2080. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Ballangrud, W.-H. Yang, D. E. Charlton, M. R. McDevitt, K. A. Hamacher, K. S. Panageas, D. Ma, N. H. Bander, D. A. Scheinberg, and G. Sgouros Response of LNCaP Spheroids after Treatment with an {{alpha}}-Particle Emitter (213Bi)-labeled Anti-Prostate-specific Membrane Antigen Antibody (J591) Cancer Res., March 1, 2001; 61(5): 2008 - 2014. [Abstract] [Full Text] |
||||
![]() |
M. R. McDevitt, E. Barendswaard, D. Ma, L. Lai, M. J. Curcio, G. Sgouros, A. M. Ballangrud, W.-H. Yang, R. D. Finn, V. Pellegrini, et al. An {{alpha}}-Particle Emitting Antibody ([213Bi]J591) for Radioimmunotherapy of Prostate Cancer Cancer Res., November 1, 2000; 60(21): 6095 - 6100. [Abstract] [Full Text] |
||||
![]() |
T. Joki, O. Heese, D. C. Nikas, L. Bello, J. Zhang, S.-K. Kraeft, N. T. Seyfried, T. Abe, L. B. Chen, R. S. Carroll, et al. Expression of Cyclooxygenase 2 (COX-2) in Human Glioma and in Vitro Inhibition by a Specific COX-2 Inhibitor, NS-398 Cancer Res., September 1, 2000; 60(17): 4926 - 4931. [Abstract] [Full Text] |
||||
![]() |
N. Kohno, T. Ohnuma, H. F. Biller, and J. F. Holland Effects of Cisplatin Plus Fluorouracil vs Cisplatin Plus Cytarabine on Head and Neck Squamous Multicellular Tumor Spheroids Arch Otolaryngol Head Neck Surg, February 1, 1988; 114(2): 157 - 161. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |